Dr. Natalie Artzi, Ph.D., has been appointed as the Associate Institute Director at the Wyss Institute for Biologically Inspired Engineering at Harvard University.
In her new role, Dr. Artzi will work closely with Founding Director Dr. Don Ingber and the senior leadership team to drive transformative advancements in biology and engineering.
She will lead multi-investigator collaborations to secure research funding and advance projects focusing on translating biologically inspired engineering into medical and environmental solutions.
Dr. Artzi's rapid progression from Associate Faculty to Core Faculty showcases her scientific impact and dedication to the Wyss Institute's mission.
Her leadership aims to foster collaboration, expand research frontiers, and strengthen partnerships across industries and philanthropic endeavors.
Dr. Artzi's research program focuses on designing nanostructures for disease diagnostics and therapeutics, especially targeting aggressive cancers and infectious diseases.
She is currently leading cutting-edge projects involving targeted drug delivery systems, immune modulation strategies, and tissue-specific adhesive hydrogels for surgical applications.
Dr. Artzi's work includes developing nanocarriers for gene and immune therapies, sustained-release delivery platforms, and microneedle arrays for minimally invasive diagnostics.
Her partnership with various experts within and outside the Institute underscores the collaborative ethos of the Wyss Institute in advancing translational nanomedicine and diagnostic technologies.
As the Associate Institute Director, Dr. Artzi plays a key role in facilitating cross-disciplinary collaboration, supporting grant proposals, and driving innovative research endeavors at the Wyss Institute.